abc27

GORE RELEASES 3-YEAR DATA FOR THE GORE® CARDIOFORM ASD OCCLUDER

Gore ASSURED Clinical Study results through 36 months demonstrate 100 percent closure success * with the GORE ® CARDIOFORM ASD Occluder, and consistent safety outcomes † across a broad range of ASD ...
TCTMD

Multiple ASD Closure Using the Interleaving Method: A Refined Strategy Utilizing Gore Cardioform Occluder Devices

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Business Insider

THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF

CAUTION: Investigational device. Limited by United States law to investigational use. The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of patent foramen ...
TCTMD

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

TCT 748: Post Infarction Ventricular Septal Defect Blockage: The "DEXTER" concept (Direct EXTernalization and Emneshment to Right ventricular moderator band) Receive the the latest news, research, and ...